Rossi, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 373
EU - Europa 60
Continente sconosciuto - Info sul continente non disponibili 47
AS - Asia 12
Totale 492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 370
IT - Italia 60
BD - Bangladesh 12
CA - Canada 1
GT - Guatemala 1
JM - Giamaica 1
Totale 445
Salva come PNG Salva come JPEG
Città #
Ashburn 50
Council Bluffs 42
Milan 38
Columbus 27
Miano 7
Atlanta 6
Memphis 4
Los Angeles 2
New York 2
Newark 2
Philadelphia 2
Allentown 1
Bay City 1
Bridgeport 1
Brooklyn 1
Buffalo 1
Calgary 1
Chicago 1
Clarksville 1
Cleburne 1
Columbia 1
Commerce City 1
Dallas 1
Darien 1
Dayton 1
Detroit 1
Fayetteville 1
Fontana 1
Galeton 1
Goodyear 1
Grand Junction 1
Guatemala City 1
Hammond 1
Hillsdale 1
Indpls 1
La Grange 1
Las Vegas 1
Liberty 1
Lindenhurst 1
Longwood 1
Louisville 1
Mansfield 1
Miami 1
Midland 1
Mira Loma 1
Missouri City 1
Montgomery Village 1
Naples 1
New Orleans 1
Norristown 1
North Augusta 1
North Charleston 1
Norwalk 1
Odenton 1
Pewaukee 1
Phenix City 1
Phoenix 1
Portland 1
Portmore 1
Queens 1
Reston 1
Riverside 1
Rome 1
Saint Cloud 1
San Francisco 1
Santa Ana 1
Somma Vesuviana 1
South Point 1
Struthers 1
Tracy 1
Union 1
Virginia Beach 1
Yardley 1
Ypsilanti 1
Totale 245
Salva come PNG Salva come JPEG
Nome #
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels 42
Cognitive effects of Lewy body pathology in clinically unimpaired individuals 37
Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder 36
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 29
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease 20
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 15
RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease 15
Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type 15
Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease 12
Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivo 11
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 11
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 10
Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: A 10-year study in Italy 10
Patient with rapidly evolving neurological disease with neuropathological lesions of Creutzfeldt-Jakob disease, Lewy body dementia, chronic subcortical vascular encephalopathy and meningothelial meningioma 10
Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease 9
Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism 9
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease 9
Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt–Jakob Disease Surveillance Network 9
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification 9
Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges 8
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies 8
MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population 8
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding 7
Improving protocols for α-synuclein seed amplification assays: Analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification 7
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum 7
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity? 7
Recent advances in the histo-molecular pathology of human prion disease 7
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 7
Alpha-synuclein RT-QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients 7
Clinical effects of Lewy body pathology in cognitively impaired individuals 6
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 6
Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies 6
Phenotypic Heterogeneity of Variably Protease-Sensitive Prionopathy: A Report of Three Cases Carrying Different Genotypes at PRNP Codon 129 6
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 6
Understanding prion strains: Evidence from studies of the disease forms affecting humans 6
Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders 6
Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants 6
Towards an improved early diagnosis of neurodegenerative diseases: The emerging role of in vitro conversion assays for protein amyloids 6
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden 6
CSF markers of neurodegeneration Alzheimer’s and Lewy body pathology in isolated REM sleep behavior disorder 6
Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol Comparison 6
Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) 5
Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease 5
High Agreement Across Laboratories Between Different Alpha‐Synuclein Seed Amplification Protocols 5
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration 5
Atypical creutzfeldt-jakob disease with prpamyloid plaques in white matter: Molecular characterization and transmission to bank voles show the M1 strain signature 5
Variably protease-sensitive prionopathy presenting within ALS/FTD spectrum 4
Totale 492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.597
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2026/2027492 1 491 0 0 0 0 0 0 0 0 0 0
Totale 492